| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |